Rong Le

Array ( [id] => 10241506 [patent_doc_number] => 20150126501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'Fused Ring Compound For Use As Mineralocorticoid Receptor Antagonist' [patent_app_type] => utility [patent_app_number] => 14/591081 [patent_app_country] => US [patent_app_date] => 2015-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20376 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14591081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10367015 [patent_doc_number] => 20150252020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'Intramolecular Hydrogen-Bonded Nitric Oxide Synthase Inhibitors' [patent_app_type] => utility [patent_app_number] => 14/589690 [patent_app_country] => US [patent_app_date] => 2015-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7128 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10367015 [patent_doc_number] => 20150252020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'Intramolecular Hydrogen-Bonded Nitric Oxide Synthase Inhibitors' [patent_app_type] => utility [patent_app_number] => 14/589690 [patent_app_country] => US [patent_app_date] => 2015-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7128 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11270454 [patent_doc_number] => 20160333002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-17 [patent_title] => 'N, N\' SUBSTITUTED PIPERIDINAMINE COMPOUNDS, AND PREPARATION METHOD AND USAGE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/105702 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 31593 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11121954 [patent_doc_number] => 20160318929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AND METHODS OF THEIR USE' [patent_app_type] => utility [patent_app_number] => 15/108400 [patent_app_country] => US [patent_app_date] => 2014-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48291 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11729283 [patent_doc_number] => 20170190726 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-07-06 [patent_title] => 'PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 15/102700 [patent_app_country] => US [patent_app_date] => 2014-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13034345 [patent_doc_number] => 10039282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-07 [patent_title] => Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides [patent_app_type] => utility [patent_app_number] => 15/104004 [patent_app_country] => US [patent_app_date] => 2014-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31745 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 256 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11729283 [patent_doc_number] => 20170190726 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-07-06 [patent_title] => 'PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 15/102700 [patent_app_country] => US [patent_app_date] => 2014-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11289111 [patent_doc_number] => 20160339043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR REDUCING INTRAOCULAR PRESSURE' [patent_app_type] => utility [patent_app_number] => 15/102201 [patent_app_country] => US [patent_app_date] => 2014-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11329 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11698770 [patent_doc_number] => 09688674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-27 [patent_title] => 'Selective EP4 receptor antagonistic substance for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 14/547247 [patent_app_country] => US [patent_app_date] => 2014-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 19628 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14547247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11075631 [patent_doc_number] => 20160272596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'TETRAHYDRO-BENZODIAZEPINONES' [patent_app_type] => utility [patent_app_number] => 15/037240 [patent_app_country] => US [patent_app_date] => 2014-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78707 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11612533 [patent_doc_number] => 09650383 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-16 [patent_title] => 'Aldose reductase inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/541365 [patent_app_country] => US [patent_app_date] => 2014-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14940 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14541365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11067594 [patent_doc_number] => 20160264558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-15 [patent_title] => 'FLUOROGENIC PROTECTING GROUP' [patent_app_type] => utility [patent_app_number] => 15/036302 [patent_app_country] => US [patent_app_date] => 2014-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9434 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11075632 [patent_doc_number] => 20160272595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'QUINAZOLINONE AND ISOQUINOLINONE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 15/030804 [patent_app_country] => US [patent_app_date] => 2014-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 73821 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9839693 [patent_doc_number] => 20150031775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'COMPOSITION AND METHOD FOR AFFECTING MALE AND FEMALE HORMONE LEVELS' [patent_app_type] => utility [patent_app_number] => 14/511844 [patent_app_country] => US [patent_app_date] => 2014-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10324 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9806609 [patent_doc_number] => 20150018551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'CYCLOALKANE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/502708 [patent_app_country] => US [patent_app_date] => 2014-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 125422 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14502708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9806481 [patent_doc_number] => 20150018426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety' [patent_app_type] => utility [patent_app_number] => 14/502552 [patent_app_country] => US [patent_app_date] => 2014-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11788 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14502552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11243610 [patent_doc_number] => 09469643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-18 [patent_title] => 'Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one' [patent_app_type] => utility [patent_app_number] => 14/493261 [patent_app_country] => US [patent_app_date] => 2014-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 20136 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14493261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11009650 [patent_doc_number] => 20160206603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'COMPOSITION COMPRISING TORASEMIDE AND BACLOFEN FOR TREATING NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/914666 [patent_app_country] => US [patent_app_date] => 2014-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 22952 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10968195 [patent_doc_number] => 20140371229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'NEW THERAPEUTIC APPROACHES FOR TREATING PARKINSON\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 14/473142 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19764 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14473142 [rel_patent_id] =>[rel_patent_doc_number] =>)